| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |